Top Markets
Coin of the day
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR
Classificação em ações #18069
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating... Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Preço da ação
$3.54
Última sincronização: 2026-09-02
Valor de mercado
$213.59M
Variação (1 dia)
3.06%
Variação (1 ano)
-3.94%
País
US
Negociar Voyager Therapeutics, Inc. (VYGR)

Categoria

Histórico de preços das ações de Voyager Therapeutics, Inc. (VYGR)
Preço de fecho mais alto: $3.48 em 2026-09-01

Preço de fecho mais baixo: $21.80 em 2015-11-01
Histórico de preços das ações da Voyager Therapeutics, Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -5.39%
2025 -31.67%
2024 -23.54%
2023 35.12%
2022 105.49%
2021 -64.56%
2020 -41.72%
2019 39.09%
2018 -32.12%
2017 8.56%
2016 -42.81%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.33 -8.75%
AU
$757.71 6.76%
CH